This estimate on the “PrEP gap” in Europe was published in a paper in Eurosurveillance stating that 500 000 men who have sex with men in the European Union currently cannot access HIV pre-exposure prophylaxis (PrEP), despite being very likely to use it.
This report summarises key issues related to HIV and people who inject drugs in Europe and Central Asia based on data provided by countries for reporting on the Dublin Declaration in 2018.
This report outlines suggested steps to develop, implement and coordinate a national STI strategy and action plan. It includes approaches to ensure the necessary stakeholder engagement for such strategies to succeed.
Targeted testing is an essential element of any strategy to eliminate viral hepatitis across the countries in the European Union and European Economic Area. Some preliminary monitoring results on the response to hepatitis B and C presented around World Hepatitis Day show that diagnosing chronic infections is still a challenge in the EU/EEA.
Since 2010, syphilis notification rates in the EU/EAA have been on the increase, but in recent years this trend seems to accelerate, predominantly among men having sex with men. Similar trends have been observed in high-income countries outside the EU/EAA. While the overall trend remained relatively stable, outbreaks or clusters of syphilis cases have also been reported among heterosexual populations in the EU/EEA. In several high-income countries (e.g. USA, Japan), increases in congenital syphilis occurred in connection with increases in syphilis notifications among women.